Published on Thursday October 05, 2023

Smooth Drug Development September 2023 News Release

We are working on the following new projects:

  • We signed a contract for medical writing activities for a BE trial with our long-term Client.

We are happy to reach the following milestones in our projects:

  • We continue enrolling patients in Russia and India into an international phase III clinical trial of an original drug for patients with chronic myeloid leukemia. 79 subjects were enrolled in India.
  • We prepared CTA submission documents for Liraglutide trial. This is a phase I trial.
  • Clinical part was started in a BE trial with Vildagliptin.
  • 3 patients were randomized in a phase III clinical trial in paroxysmal nocturnal hemoglobinuria.
  • Clinical part is finished in BE trials with Empagliflozin, 10 mg and 25 mg.
  • 1022 subjects are enrolled in an observational program of multivitamins in pregnant and childbearing women.